Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung

Purpose: To evaluate the potential of cone-beam-CT (CB-CT) guided adaptive radiotherapy (ART) for locally advanced non-small cell lung cancer (NSCLC) for sparing of surrounding organs-at-risk (OAR). Materials and Methods: In 10 patients with locally advanced NSCLC, daily CB-CT imaging was acquired d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoegen-Saßmannshausen, Philipp (VerfasserIn) , Akbaba, Sati (VerfasserIn) , El-Shafie, Rami (VerfasserIn) , Weykamp, Fabian (VerfasserIn) , König, Laila (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Hörner-Rieber, Juliane (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 09 December 2020
In: Frontiers in oncology
Year: 2020, Jahrgang: 10
ISSN:2234-943X
DOI:10.3389/fonc.2020.564857
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fonc.2020.564857
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fonc.2020.564857/full
Volltext
Verfasserangaben:Philipp Hoegen, Clemens Lang, Sati Akbaba, Peter Häring, Mona Splinter, Annette Miltner, Marion Bachmann, Christiane Stahl-Arnsberger, Thomas Brechter, Rami A. El Shafie, Fabian Weykamp, Laila König, Jürgen Debus and Juliane Hörner-Rieber

MARC

LEADER 00000caa a2200000 c 4500
001 174310569X
003 DE-627
005 20210820111434.0
007 cr uuu---uuuuu
008 201217s2020 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2020.564857  |2 doi 
035 |a (DE-627)174310569X 
035 |a (DE-599)KXP174310569X 
035 |a (OCoLC)1264393469 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hoegen-Saßmannshausen, Philipp  |d 1987-  |e VerfasserIn  |0 (DE-588)1162715278  |0 (DE-627)1026887836  |0 (DE-576)507591283  |4 aut 
245 1 0 |a Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung  |c Philipp Hoegen, Clemens Lang, Sati Akbaba, Peter Häring, Mona Splinter, Annette Miltner, Marion Bachmann, Christiane Stahl-Arnsberger, Thomas Brechter, Rami A. El Shafie, Fabian Weykamp, Laila König, Jürgen Debus and Juliane Hörner-Rieber 
264 1 |c 09 December 2020 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.12.2020 
520 |a Purpose: To evaluate the potential of cone-beam-CT (CB-CT) guided adaptive radiotherapy (ART) for locally advanced non-small cell lung cancer (NSCLC) for sparing of surrounding organs-at-risk (OAR). Materials and Methods: In 10 patients with locally advanced NSCLC, daily CB-CT imaging was acquired during radio- (n=4) or radiochemotherapy (n=6) for simulation of ART. Patients were treated with conventionally fractionated intensity-modulated radiotherapy (IMRT) with total doses of 60-66 Gy (pPlan) (311 fraction CB-CTs). OAR were segmented on every daily CB-CT and the tumor volumes were modified weekly depending on tumor changes. Doses actually delivered were recalculated on daily images (dPlan), and voxel-wise dose accumulation was performed using a deformable registration algorithm. For simulation of ART, treatment plans were adapted using the new contours and re-optimized weekly (aPlan). Results: CB-CT showed continuous tumor regression of 1.1±0.4% per day, leading to a residual gross tumor volume (GTV) of 65.3±13.4% after 6 weeks of radiotherapy (p=0.005). Corresponding PTVs decreased to 83.7±7.8% (p=0.005). In the actually delivered plans (dPlan), both conformity (p=0.005) and homogeneity (p=0.059) indices were impaired compared to the initial plans (pPlan). This resulted in higher actual lung doses than planned: V20Gy was 34.6±6.8% instead of 32.8±4.9% (p=0.066), mean lung dose was 19.0±3.1 Gy instead of 17.9±2.5 Gy (p=0.013). The generalized equivalent uniform dose (gEUD) of the lung was 18.9±3.1 Gy instead of 17.8±2.5 Gy (p=0.013), leading to an increased lung normal tissue complication probability (NTCP) of 15.2±13.9% instead of 9.6±7.3% (p=0.017). Weekly plan adaptation enabled decreased lung V20Gy of 31.6±6.2% (-3.0%, p=0.007), decreased mean lung dose of 17.7±2.9 Gy (-1.3 Gy, p=0.005) and decreased lung gEUD of 17.6±2.9 Gy (-1.3 Gy, p=0.005). Thus, resulting lung NTCP was reduced to 10.0±9.5% (-5.2%, p=0.005). Target volume coverage represented by conformity and homogeneity indices could be improved by weekly plan adaptation (CI: p=0.007, HI: p=0.114) and reached levels of the initial plan (CI: p=0.721, HI: p=0.333). Conclusion: IGRT with CB-CT detects continuous GTV and PTV changes. CB-CT-guided ART for locally advanced NSCLC is feasible and enables superior sparing of healthy lung at high levels of plan conformity. 
700 1 |a Akbaba, Sati  |d 1987-  |e VerfasserIn  |0 (DE-588)1150864648  |0 (DE-627)1011125226  |0 (DE-576)497297116  |4 aut 
700 1 |a El-Shafie, Rami  |d 1989-  |e VerfasserIn  |0 (DE-588)110057378X  |0 (DE-627)859521427  |0 (DE-576)469743859  |4 aut 
700 1 |a Weykamp, Fabian  |d 1987-  |e VerfasserIn  |0 (DE-588)1072433036  |0 (DE-627)827655096  |0 (DE-576)43385992X  |4 aut 
700 1 |a König, Laila  |d 1986-  |e VerfasserIn  |0 (DE-588)1053640579  |0 (DE-627)790403315  |0 (DE-576)409584282  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Hörner-Rieber, Juliane  |d 1985-  |e VerfasserIn  |0 (DE-588)1025307631  |0 (DE-627)722020511  |0 (DE-576)370188039  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 10(2020) Artikel-Nummer 564857, 10 Seiten  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung 
773 1 8 |g volume:10  |g year:2020  |g extent:10  |a Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung 
856 4 0 |u https://doi.org/10.3389/fonc.2020.564857  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fonc.2020.564857/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20201217 
993 |a Article 
994 |a 2020 
998 |g 1025307631  |a Hörner-Rieber, Juliane  |m 1025307631:Hörner-Rieber, Juliane  |d 910000  |d 911400  |d 50000  |e 910000PH1025307631  |e 911400PH1025307631  |e 50000PH1025307631  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 14  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 13 
998 |g 1053640579  |a König, Laila  |m 1053640579:König, Laila  |d 910000  |d 911400  |e 910000PK1053640579  |e 911400PK1053640579  |k 0/910000/  |k 1/910000/911400/  |p 12 
998 |g 1072433036  |a Weykamp, Fabian  |m 1072433036:Weykamp, Fabian  |d 910000  |d 911400  |e 910000PW1072433036  |e 911400PW1072433036  |k 0/910000/  |k 1/910000/911400/  |p 11 
998 |g 110057378X  |a El-Shafie, Rami  |m 110057378X:El-Shafie, Rami  |d 910000  |d 911400  |e 910000PE110057378X  |e 911400PE110057378X  |k 0/910000/  |k 1/910000/911400/  |p 10 
998 |g 1150864648  |a Akbaba, Sati  |m 1150864648:Akbaba, Sati  |p 3 
998 |g 1162715278  |a Hoegen-Saßmannshausen, Philipp  |m 1162715278:Hoegen-Saßmannshausen, Philipp  |d 910000  |d 911400  |e 910000PH1162715278  |e 911400PH1162715278  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN174310569X  |e 3826488806 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Philipp Hoegen, Clemens Lang, Sati Akbaba, Peter Häring, Mona Splinter, Annette Miltner, Marion Bachmann, Christiane Stahl-Arnsberger, Thomas Brechter, Rami A. El Shafie, Fabian Weykamp, Laila König, Jürgen Debus and Juliane Hörner-Rieber"]},"id":{"eki":["174310569X"],"doi":["10.3389/fonc.2020.564857"]},"person":[{"role":"aut","given":"Philipp","family":"Hoegen-Saßmannshausen","display":"Hoegen-Saßmannshausen, Philipp"},{"display":"Akbaba, Sati","family":"Akbaba","given":"Sati","role":"aut"},{"family":"El-Shafie","given":"Rami","role":"aut","display":"El-Shafie, Rami"},{"display":"Weykamp, Fabian","role":"aut","given":"Fabian","family":"Weykamp"},{"display":"König, Laila","role":"aut","given":"Laila","family":"König"},{"family":"Debus","role":"aut","given":"Jürgen","display":"Debus, Jürgen"},{"display":"Hörner-Rieber, Juliane","role":"aut","given":"Juliane","family":"Hörner-Rieber"}],"relHost":[{"id":{"eki":["684965518"],"issn":["2234-943X"],"zdb":["2649216-7"]},"part":{"extent":"10","volume":"10","text":"10(2020) Artikel-Nummer 564857, 10 Seiten","year":"2020"},"title":[{"title_sort":"Frontiers in oncology","title":"Frontiers in oncology"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 07.11.13"],"origin":[{"dateIssuedDisp":"2011-","dateIssuedKey":"2011","publisherPlace":"Lausanne","publisher":"Frontiers Media"}],"pubHistory":["2011 -"],"disp":"Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lungFrontiers in oncology","recId":"684965518","physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"09 December 2020"}],"title":[{"title_sort":"Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung","title":"Cone-Beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung"}],"note":["Gesehen am 17.12.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"174310569X","physDesc":[{"extent":"10 S."}]} 
SRT |a HOEGENSASSCONEBEAMCT0920